Higher concentrations of the inflammatory biomarker C-reactive protein (CRP) have been associated with a moderately higher risk of colorectal cancer (CRC) in a meta-analysis of eighteen prospective studies [8], although significant heterogeneity was observed across individual studies. The gene discussed is CRP; the disease is colorectal cancer.